Gate2Tech managing director Dr Jean Michel Pommet explains why the Probiotech conference, to be held in Milan on June 23-24, offers something a little bit different as far as probiotic-centred congresses go.
The marine environment may be hiding a bounty of untapped natural ingredients that have potential for use in foods and supplements, says Dr Jon Williams of Aquapharm.
The long-standing dispute within the cranberry industry about the most appropriate way to measure the urinary tract infection (UTI)-battling berry’s active constituents was resolved in France recently when a government body backed a version of the DMAC...
At Vitafoods Europe 2011, Jess Halliday caught up with event director Chris Lee to talk about the show’s ambitious expansion plans into Asia and South America.
DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why the company is not finished spending yet.
Global pomegranate juice leader POM Wonderful has spent a large part of 2010 locking horns with the Federal Trade Commission over health claims for its juices and dietary supplements.
The rejection of so many health claim submissions by the European Food Safety Authority is creating a major headache for the EU functional foods and food supplements industries, with many looking at resubmissions under article 13.5 of the regulation.
The tough health claims environment in Europe could turn manufacturers towards more subtle – and maybe less ethical – marketing approaches, believes Henry Dixon of PR firm BDB.
A new microencapsulation technique that produces smaller more uniform particles could replace less accurate microencapsulation techniques, according to researchers at Dutch institute TNO.
Should the FDA work to be more like EFSA? Speaking at the NutraIngredients Health Claims 2010 conference Andrew Shao said the two organisations are already very similar in the way they review scientific claims.
Dispatches from NutraIngredients Health Claims 2010
EFSA’s opinions on health claims are couched in scientific language that food and beverage manufacturers would be unlikely to use on product packaging. Unilever’s director of external affairs explains the need for linguistic flexibility.
David Peters, head of business development at Swedish life sciences firm Biovelop discusses how his firm has worked to overcome poor perceptions of oat-based beta-glucans by improving their aesthetic and technical qualities.
Last month the European Food safety Authority (EFSA) rejected a range of whey-based, article 13.1 health claims, with only a muscle mass claim gaining approval. Problem? Not according to the whey industry.
Henry Hussell, the head of marketing, Europe at Cargill Health and Nutrition, acknowledges the development of its plant sterols and beta glucan has been slower than many expected – but that doesn’t mean the agrofood giant has lost faith in them.
The quality of research backing omega-3s such as DHA and EPA has had vindicated with the fatty acids receiving more positive health claim opinions than any other nutrient in Europe’s tough new health claims regime. Only vitamins and minerals have performed...
Lipid Nutrition global group manager in marketing, John Kurstjens, is “a little bit disappointed” about the recent EFSA health claim opinion on CLA which included a range of claim dismissals but remained strangely silent about the claim that matters most...
The world’s two biggest herbal extract suppliers respond to the recent European Commission decision to temporarily remove botanicals from the European Union health claims process.
The European Food Safety Authority should be able to deliver health claim opinions based on products that have had ingredients like fermented carbohydrates removed from them, says Beneo.
Research in North America, Europe and Asia shows that consumers understand fibre and the potential health benefits, and there is a strong consumer demand, says Tate & Lyle’s Sandra Einerhand.
Positioning and marketing beauty from within products presents a unique set of challenges that require a clear and targeted strategy, explains Imedeen marketing director Marie-Louise Haxthausen.
Are beauty from within products covered by the health claims regulation? Eversheds lawyer Owen Warnock explains the grey area between beauty and health – and why the lack of clarity may eventually go to court.
Much more is known about how probiotics work in the gut, than for the skin, but it seems there are signals coming from gut micro-organisms to the skin and mucosa that may allow interaction between probiotics in the gut and effects on the skin.
At the recent IFT Annual Meeting and Expo, Stephen Daniells talked to Dr Jim Kaput, director of FDA’s Division of Personalized Nutrition and Medicine about the paradigm shift needed to move personalized nutrition forward.
The controversy surrounding antioxidant science is not being helped by a lack of validated biomarkers, says Professor Wilhem Stahl, an antioxidant researcher at the University of Dusseldorf. Which doesn’t mean they are due any time soon.
A European Union health claim rejection hasn’t dampened the spirits of global cranberry leader, Ocean Spray, which has continued to invest in science for urinary tract infections and frontier areas.
Dr Peter Hollman has spent 30 years researching polyphenols which has led him to the conclusion they don’t work as antioxidants when ingested in foods and supplements because the human body makes enough of its own. But that doesn’t mean they aren’t useful...
Dr Mary Gilsenen, head of regulatory services at Leatherhead Food Research explains why simply using the term ‘antioxidant’ on a product can be a health claim.
Dr David Vauzour, a post-doctorate fellow at the University of Reading, is leading research into how antioxidants may improve brain function - with animal studies throwing up interesting results.
Anthony Hehir, market development manager, Europe, Middle East and Africa, DSM Nutritional products tells Shane Starling about the reasoning behind the company’s new health benefit-based portfolio.
Scott Bush, the VP of marketing, health and nutrition in Bioactives at Danisco USA, talks to Stephen Daniells about the challenges the probiotics industry faces in the form of new European Union health claims laws.
Vitafoods event director Chris Lee explains the massive opportunity that awaits Vitafoods Asia exhibitors in Hong Kong in 2011, and hints at further new locations in the future.
A negative opinion from EFSA on a health claim is not necessarily the end of the line for marketing the products benefits, and avenues to market the product are still available, says a UK-based lawyer.
Welcome to this seasonal holiday video from Decision News Media.As we prepare to celebrate our tenth anniversary next year and first year as part of William Reed Business Media, we present 10 fun number facts about our company. And, later this week, the...
Dispatches from the NI Health Claims 2010 conference
Concerns abound that the approach of the European Food Safety Authority towards health claims may stifle innovation and science, none more so than for prebiotics, says a leading researcher.
Dispatches from the NI Health Claims 2010 conference
Europe's leading trade groups are set for a meeting with the European Commission to discuss their concerns over the health claims assessment, and EFSA's reluctance to engage in dialogue.
Dispatches from the NI Health Claims 2010 conference
Making claims based on non-conclusive but still substantial science is a "possible avenue" since denying a 'maybe' claim may challenge free speech rights, says a UK lawyer.
Dispatches from the NI Health Claims 2010 conference
US attorney Jonathan Emord draws parallels between his experiences in the US challenging the Food and Drug Administration (FDA) and the current health claims situation in Europe on the basis of free speech.
The main consumer trends in Russia are parallel to those in Europe, says Fortitech Europe’s managing director: Health and nutrition are of prime concern, and baby boomers bring opportunities in bone health, skin health and mental acuity.
The affirmation that the omega-3 DHA can benefit cognitive and eye health offers hope to previously rejected claims. And it's business as usual regarding the overall health claims process, despite ratification of the Lisbon Treaty, said a European...
With ‘healthy’ populations identified as the ideal for the European Food Safety Authority’s health claims, NutraIngredients asks Yakult – what exactly is healthy?
Producing randomized clinical trials is never an inexpensive endeavour, but increasingly stringent criteria mean companies are facing tough choices on whether to pursuer innovation, says DSM Nutritional Products.
Leatherhead Food Research chief executive, Dr Paul Berryman, tells Shane Starling that despite a swathe of European Food Safety Authority (EFSA) health claim rejections, the positive opinions that have come in offer much hope to industry.
As the European Union health claims climate evolves, companies are learning just what is required to demonstrate the benefits of healthy foods and supplements.
As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we stand and how to get the good ship Probiotic back on course.
Four major Irish dairy ingredient players and four academic institutions form the nexus of a new Irish initiative to develop functional food ingredients – Food for Health Ireland.
The Sudzucker-owned Beneo Group established the Beneo Institute in late 2009 to give “new oxygen to a squeezed industry”, as Executive Board member, Yves Servotte, puts it, to a functional foods industry facing unprecedented regulatory and scientific...
